Towards a sustainable pricing of pharmaceutical goods: comment
- PMID: 40381144
- DOI: 10.1007/s11739-025-03979-3
Towards a sustainable pricing of pharmaceutical goods: comment
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no conflict of interest. Human and animal rights statement: Not applicable. Informed consent: Not applicable.
References
-
- Ciccocioppo R, Cuende N (2025) Towards a sustainable pricing of pharmaceutical goods. Intern Emerg Med 20:957–958. https://doi.org/10.1007/s11739-024-03785-3 - DOI - PubMed
-
- Morgan SG, Bathula HS, Moon S (2020) Pricing of pharmaceuticals is becoming a major challenge for health systems. BMJ 368:l4627. https://doi.org/10.1136/bmj.l4627 - DOI - PubMed
-
- Garattini L, Finazzi B, Mannucci PM (2022) Pharmaceutical pricing in Europe: time to take the right direction. Intern Emerg Med 17:945–948. https://doi.org/10.1007/s11739-022-02960-8 - DOI - PubMed
-
- Frakt AB, Chernew ME (2018) The Importance of Relative Prices in Health Care Spending. JAMA 319:441–442. https://doi.org/10.1001/jama.2017.20047 - DOI - PubMed
-
- Garattini L, Finazzi B, Mazzone A (2025) Pharmaceutical policy in europe: Time for a common priceless solution? Eur J Intern Med S0953–6205(25):00168–00172. https://doi.org/10.1016/j.ejim.2025.04.026 - DOI
Publication types
LinkOut - more resources
Full Text Sources